Compounds > farnesol

farnesol and B16 Melanoma

farnesol has been researched along with B16 Melanoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halaschek-Wiener, J; Jansen, B; Kloog, Y; Wacheck, V1
Ben-David, E; Eichler, H; Gana-Weisz, M; Heere-Ress, E; Jansen, B; Kahr, H; Kloog, Y; Mayer, BX; Pehamberger, H; Schlagbauer-Wadl, H; Wolff, K1
Elson, CE; Jung, M; Mo, H; Tatman, D1

Other Studies

3 other study(ies) available for farnesol and B16 Melanoma

ArticleYear
Farnesyl thiosalicylic acid chemosensitizes human melanoma in vivo.
    The Journal of investigative dermatology, 2003, Volume: 120, Issue:1

    Topics: Animals; Antineoplastic Agents; Dacarbazine; Enzyme Inhibitors; Farnesol; Female; Humans; Melanoma, Experimental; Mice; Mice, SCID; Neoplasm Transplantation; ras Proteins; Salicylates; Transplantation, Heterologous; Tumor Cells, Cultured

2003
Novel Ras antagonist blocks human melanoma growth.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Nov-23, Volume: 96, Issue:24

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Line, Transformed; Enzyme Inhibitors; Farnesol; Fibroblasts; Growth Inhibitors; Humans; Melanoma, Experimental; Mice; Mice, SCID; Neoplasm Transplantation; ras Proteins; Rats; Salicylates; Transplantation, Heterologous; Tumor Cells, Cultured

1999
Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas.
    Cancer letters, 2000, Sep-01, Volume: 157, Issue:2

    Topics: Acyclic Monoterpenes; Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cholesterol; Dose-Response Relationship, Drug; Farnesol; Melanoma, Experimental; Mice; ortho-Aminobenzoates; Terpenes; Tumor Cells, Cultured

2000